Aktien Sensor

New China Life Insurance has reported its quarterly earnings, with a price-to-earnings ratio of 6.18 and a price-to-book ratio of 2.1, amidst a 52-week stock price fluctuation.

New China Life Insurance Co Ltd’s stock price has surged due to improved market sentiment and increased demand for insurance services driven by the Chinese government’s economic stimulus efforts.

China Life Insurance Co Ltd’s stock price has experienced wild fluctuations, increasing from a low of 15.52 HKD in September 2024 to 53.42 HKD as of May 13, 2025, amidst overall market trend growth in the insurance sector.

New China Life Insurance’s quarterly earnings have been met with a mixed reaction, with the company’s stock price experiencing a decline, but also surpassing its 52-week low.

New China Life Insurance’s stock price has plummeted to 28.5 HKD, sparking concerns about the company’s future prospects and prompting investors to reassess their portfolios.

New China Life Insurance has reported a 100%+ increase in net profit, driven by improved investment returns and a surge in sales, solidifying its position as a leader in the Chinese insurance market.

New China Life Insurance Co Ltd’s stock price surged 1.8% on March 14, 2024, in tandem with the broader market’s 1.8% and 2.2% gains in the Shanghai Composite and ChiNext Indices, respectively.

New China Life Insurance has invested 500 billion yuan in China’s stock market through its private equity fund, Hunghui Fund, leading the charge in the country’s stock market and paving the way for other insurance companies to follow.

New China Life Insurance solidifies its position in the market with the successful acquisition of CBA’s stake in Bank of Hangzhou for $594 million.

New China Life Insurance solidifies its position in the market with the successful acquisition of CBA’s stake in Bank of Hangzhou for $594 million.